查詢結果分析
來源資料
相關文獻
- Persistent or Recurrent Peptic Ulcer in Patients with Negative Urea Breath Test after H. Pylori Eradication and Proton Pump Inhibitor Therapy
- C丨 Urea Breath Test Combined with Symptomatology is Helpful in Deciding Which Dyspeptic Patients Need Endoscopy to Rule in Peptic Ulcer
- 消化性潰瘍的元兇--幽門螺旋桿菌
- 醇提大黃對消化性潰瘍合併幽門螺旋桿菌感染之作用探討
- 幽門螺旋桿菌根除治療對消化性潰瘍復發的效益評估
- Current Treatment of Helicobacter Pylori Infection and Peptic Ulcer Disease
- Omeprazole Plus Amoxicillin Versus Triple Therapy Eradicates Helicobacter Pylori in the Chinese with Peptic Ulcer Disease
- 幽門螺旋桿菌與消化性潰瘍--根除療法與治療指南
- Patient Factors Affecting Helicobacter Pylori Eradication Therapy
- 消化性潰瘍疾病與幽門螺旋桿菌
頁籤選單縮合
題 名 | Persistent or Recurrent Peptic Ulcer in Patients with Negative Urea Breath Test after H. Pylori Eradication and Proton Pump Inhibitor Therapy=持續或復發的消化性潰瘍存在於經過幽門螺旋桿菌滅菌及氫離子阻斷劑治療後尿素呼氣測試陰性的病患 |
---|---|
作 者 | 陳立偉; 林昆儒; 張良慈; 林志榮; 簡榮南; | 書刊名 | 臺灣消化醫學雜誌 |
卷 期 | 30:2 2013.06[民102.06] |
頁 次 | 頁190-198 |
分類號 | 415.526 |
關鍵詞 | 內視鏡檢; 幽門螺旋桿菌; 消化性潰瘍; 尿素呼氣測試; Endoscopy; Helicobacter pylori; Peptic ulcer; Urea breath test; |
語 文 | 英文(English) |
中文摘要 | 背景/ 目的: 對於有消化性潰瘍及胃幽門螺旋桿菌感染的病患,尿素呼氣測試普遍應用在評估胃幽門螺旋桿菌感染的情形及滅菌的成效。胃鏡追蹤並不是一種例行檢查。本研究的目的想要知道如果病患經過胃幽門螺旋桿菌滅菌及消化性潰瘍治療後,碳14 尿素呼氣測試結果為陰性(代表滅菌成功) 的病患中,仍然存在活動性潰瘍的比例有多大。病患及方法:從2009 年6 月到2010 年12 月,總共有165 位合併胃或十二指腸潰瘍及幽門螺旋桿菌感染的病患,到基隆長庚醫院診治被收入本實驗。所有病患都接受一個星期的標準三合一胃幽門螺旋桿菌滅菌及八週的氫離子阻斷劑治療。在治療前及治療後都接受胃鏡切片檢查、快速尿素酶測試及碳14尿素呼氣測試。結果: 治療前的碳14尿素呼氣測試數值高低無法預測胃幽門螺旋桿菌滅菌成功與否。治療後在尿素呼氣測試結果為陽性的病患中有23.5%的病患有活動性的潰瘍;在尿素呼氣測試結果為陰性的病患中有9.8% 的病患有活動性的潰瘍 (p = 0.20).在多變項分析中,年紀大於65歲是預測在尿素呼氣測試結果為陰性的情況下仍然有活動性潰瘍的最重要因子(odds ratio = 7.3, 95% CI = 2.09-25.44, p = 0.002)。結論:治療前的碳14尿素呼氣測試數值高低,無法預測胃幽門螺旋桿菌滅菌成功與否。經過一週標準三合一滅菌及八週的氫離子阻斷劑治療,雖然病患的尿素呼氣測試已呈陰性,但仍然有9.8%的病患有活動性潰瘍。年紀大於65歲是預測仍然有活動性潰瘍的重要因子。 |
英文摘要 | Background and Aims: For patients with Helicobacter pylori (H. pylori) infection-related peptic ulcer,urea breath test (UBT) is usually performed to evaluate the success of H. pylori eradication therapy. Follow-upesophagogastroduodenoscopy is not a routine practice after treatment. This study aims to elucidate the possibilityof active peptic ulcers in the patients with negative result of UBT following H. pylori eradication and proton pumpinhibitor (PPI) therapy.Materials and Methods: A total of 165 patients with peptic ulcer (gastric and duodenal ulcers) and H. pyloriinfection were consecutively enrolled between June 2009 and November 2010. Endoscopic biopsy, rapid urease test(RUT) and 14C-UBT were performed in all patients before and after 1 week of standard triple H. pylori eradicationtherapy and an 8-week course of PPI treatment.Results: Pre-treatment 14C-UBT values could not predict the success of H. pylori eradication therapy. Aftertreatment, active duodenal ulcers were found in 23.5% of patients with a positive follow-up UBT result, while activeduodenal ulcers were present in 9.8% patients with a negative follow-up UBT result (p = 0.20). In the multivariateanalysis, old age (>65 years) was the most important factor for persistence of active peptic ulcers in patients withnegative follow-up UBT results (odds ratio [OR]=7.3, 95% confidence interval =2.09-25.44, p = 0.002).Conclusions: Pretreatment 14C-UBT values could not predict the success of H. pylori eradication therapy.After H. pylori eradication and 8-week PPI treatment, active peptic ulcers could still be discerned by endoscopy in9.8% patients whose follow-up UBT results were negative. Old age (>65 years) might be the single most importantfactor for persistence of active peptic ulcers in these patients. |
本系統中英文摘要資訊取自各篇刊載內容。